When it comes to CBN however, the case is a bit different because CBN is yet to be approved as a drug and so it does not fall under the jurisdiction of this law yet. The rule exempts products that are already being marketed as food and dietary supplements which CBN is already been marketed as. This means that since CBN is already been marketed as dietary supplements prior to FDA clinical investigation of CBN as a drug, it won’t be covered under the non-exempt drug rule. This stands sure as long as manufacturers stay clear of unapproved health claims.
New aggregated polls reveal that 55% of respondents believe marijuana is not dangerous, and a…
Every Croptober, growers waste time on folklore instead of physics. We break down the science…
Leafly's 2026 cannabis voter guide for the midterms is the only plan you need to…
Come along on an Emerald Triangle road trip with Lindsay MaHarry to see some of…
This month an Iowa church got what every sacramental-plant congregation dreams about: a path to…
The cannabis industry does not need another study, another tax revenue report, or another state-level…